Questions & Answers
Anthrax - Production Issues
Back to Parent Q&A Category Back to All Anthrax Q&A Back to All Q&A Back to Anthrax

FDA Inspections

Questions
Answers
  1. FDA Inspections of the Anthrax Vaccine Manufacturing Facility
    1. September 9, 1969
    2. August 3-4, 1970
    3. April 11-12, 1972
    4. September 18-19, 1972
    5. July 24-25, 1973
    6. July 26, 1973
    7. October 15-16, 1974
    8. April 16, 1975
    9. October 21, 1975
    10. April 5, 1976
    11. October 28-29, 1976
    12. March 14, 1977
    13. April 13-14, 1978
    14. May, 3,5,8,10,12,15,1978
    15. June 6-8, 1979
    16. October 18, 19, 25, 26, Nov 6, 1979
    17. April 20, May 1, 1980
    18. May 21, 1980
    19. March 25, 1981
    20. June 28-29, 1982
    21. July 11, August 11, 1982
    22. October 26-28, 1982
    23. May 2-4, 1983
    24. September 21-22, 1983
    25. June 25-27, 1984
    26. August 15-16, 1984
    27. July 8-9, 1985
    28. November 18-20, 1985
    29. August 6-8, 1986
    30. June 4-5, 1987
    31. August 26-28, 1987
    32. April 26-27, 1988
    33. September 26-27, 1988
    34. May 30- June 1, 1989
    35. July 10-12, 1989
    36. September 12-13, 1990
    37. September 9-10, 1991
    38. June 30- July 1, 1992
    39. July 29-31, 1992
    40. August 31- September 2, 1992
    41. January 14-15, 1993
    42. May 4-7, 1993
    43. May 31- June 3, 1994
    44. July 25-26, 1994
    45. April 24- May 5, 1995
    46. November 18-27, 1996
    47. February 4-20, 1998
    48. October 19-23, 1998
    49. November 15-23, 1999
    50. October 10 - 26, 2000
    51. December 11-14, 2001
    52. September 4-13, 2002
    53. May 11-20, 2004
    54. May 9-18, 2006


  2. What were the recent FDA actions related to the anthrax vaccine (BioThrax)?
    On December 15, 2005, the Food and Drug Administration released a Final Rule and Final Order for anthrax vaccine. After reviewing extensive scientific evidence and carefully considering comments from the public, the FDA determined that anthrax vaccine is safe and effective in preventing anthrax disease regardless of route of exposure, including inhalation anthrax.